Toward highly accurate and fast variant and de novo mutation identification from high-throughput sequencing data by joint Bayesian family calling 
Motivation and Objectives
Whole-genome sequencing (WGS) has become a fundamental tool in human disease research and is being adopted in clinical settings at an unprecedented rate. Whole-genome and exome sequencing has been successful in the elucidation of highly penetrant genes in early childhood diseases and its making inroads in complex trait studies entailing thousands of samples. As WGS becomes faster and moves into the clinic, e.g. into neonatal ICUs (Saunders et al., 2012) and in prenatal screening (Talkowski et al., 2012) , there is an unmet need for both speed and accuracy in the analysis workflow. Due to its shotgun nature, mis-mapping of short reads in complex genomic regions and high sequencing error rates, calling variants from human high-throughput sequencing (HTS) data still results in substantial false positives and false negatives (Ajay et al., 2011) . The problem is magnified when looking for de novo mutations in affected offspring of families, as this enriches for sequencing artifacts (Veltman and Brunner, 2012) . This is problematic since de novo mutations are thought to be responsible for about half of all early neurodevelopmental childhood disorders (Veltman and Brunner, 2012) and likely a similar fraction of neonatal/prenatal cases (Saunders et al., 2012; Talkowski et al., 2012) .
Methods
In order to alleviate these problems, we developed a joint Bayesian calling framework which calls variants simultaneously across a pedigree leveraging shared haplotypes in its members and incorporating a Mendelian segregation model, to produce accurate variant and de novo mutation calls from HTS data. We present how our Bayesian framework escapes combinatorial explosion (as compared to more simplistic approaches), is highly scalable to large pedigrees, can deal with low coverage and missing data, and can call de novo mutations if desired (Conrad et al., 2011) . Coupled with our fast alignment method, a family of three 40X whole genomes can collectively be analyzed from reads to variant calls in ~30 hours on a single commodity server, and is amenable to large-scale parallelization for further speed improvements. To validate our method, we analyzed WGS data from a 3-generation CEPH family of 17 members produced by Illumina Inc. as part of their "Platinum Genomes" resource(). Each genome was sequenced with the HiSeq ® 2500 system to 40X average depth using 2x100bp libraries of ~350bp insert size. We aligned reads and performed calls in 3 nuclear family subsets and the entire pedigree for comparison.
Results and Discussion
We focus our analysis on NA12878, a female in the second generation, for which extensive orthogonal validation data exists including fosmidend Sanger sequence data (Kidd et al., 2008) , Complete Genomics WGS data, OMNI SNP-array genotype data (Consortium et al., 2013) and experimentally validated germline and cell-line somatic de novo mutation data (Conrad et al., 2011) . As compared to naïve singleton calling, our family caller produced more high quality SNV/indel/MNP calls and eliminates low quality calls, as judged by commonly used quality metrics such as Ti/Tv, Het/Hom ratios, and dbSNP/ OMNI array concordance. All this with a low 2.5% FP rate as assessed by variants called at monomorphic sites in the OMNI array (Consortium et al., 2013) ; cf. 
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As compared with the Conrad et al (Conrad et al., 2011) validated de novo mutations set, we observed 96% and 92% sensitivity in detecting reported germline and de novo mutations, respectively (note that the cell line batch may be different and thus have different somatic mutations). While high sensitivity can be achieved by simply reporting variants that pass less stringent accuracy thresholds (and in so doing increasing substantially the number of variants that violate Mendelian segregation), our family calling achieves high sensitivity, delivering a 10X reduction in Mendelian errors from 101,204 to 8,672 (cf. Table 1) . A further 10X reduction in Mendelian violations can be achieved without using the de novo priors, which would be appropriate when assuming inherited disease. Through the analysis of variant segregation to the third generation, we confirmed 99% of the Conrad et al (Conrad et al., 2011) germline mutations (somatic variants do not segregate, as expected) and observed about ~250 new de novo mutation candidates, which is close to expectation (about 100 from previous studies (Conrad et al., 2011) ). Importantly, the high de novo sensitivity of 96% was achieved while reducing the number of candidate de novo mutations by greater than 6-fold, from 16,902 candidates to 2,667 de novo candidates, without using empirical filters (this is ongoing work we will report at the conference). Our results suggest that joint family calling produces more accurate calls than singleton calling and allows for the assessment of de novo mutation candidates with much less noise. We illustrate the impact of an improved call set in the downstream interpretation analysis of a simulated cased from the literature, and a real case from a cardio-pulmonary syndrome. We believe the analytical advances we present are crucial for the clinical adoption of genome and exome sequence data in family disease studies and beyond. 
